Nanoparticles for Improved Local Retention after Intra-Articular Injection into the Knee Joint

被引:72
作者
Morgen, Michael [1 ]
Tung, David [2 ]
Boras, Britton [3 ,4 ]
Miller, Warren [1 ]
Malfait, Anne-Marie [5 ]
Tortorella, Micky [6 ]
机构
[1] Bend Res Inc, Bend, OR 97701 USA
[2] BioMed Valley Discoveries, Kansas City, MO USA
[3] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[4] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA
[5] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[6] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Beijing, Peoples R China
关键词
cross-linked hydrogels; increased retention; intra-articular injection; nanoparticles; POLY(L-LACTIC ACID) MICROSPHERES; IN-VITRO; METHOTREXATE; DELIVERY; LIPOSOMES; CELECOXIB; EFFICACY; MATRIX; FLUID;
D O I
10.1007/s11095-012-0870-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To evaluate using cationic polymeric nanoparticles that interact with hyaluronate to form ionically cross-linked hydrogels to increase the intra-articular retention time of osteoarthritis drugs in the synovial cavity. In vitro tests included nanoparticle release from cross-linked hydrogels using syringe and membrane dissolution tests, viscosity measurement of synovial fluid containing hydrogels, and release-rate measurement for a model active conjugated to a cationically substituted dextran using a hydrolyzable ester linkage in a sink dissolution test. Nanoparticle retention after intra-articular injection into rat knees was measured in vivo using fluorescence molecular tomography. Diffusional and convective transport of cationic nanoparticles from ionically cross-linked hydrogels formed in synovial fluid was slower in vitro than for uncharged nanoparticles. Hydrogels formed after the nanoparticles were mixed with synovial fluid did not appreciably alter the viscosity of the synovial fluid in vitro. In vitro release of a conjugated peptide from the cationic nanoparticles was approximately 20% per week. After intra-articular injection in rat knees, 70% of the nanoparticles were retained in the joint for 1 week. This study demonstrates the feasibility of using cationic polymeric nanoparticles to increase the retention of therapeutic agents in articular joints for indications such as osteoarthritis.
引用
收藏
页码:257 / 268
页数:12
相关论文
共 38 条
[1]  
Babcock WC, 2009, United States patent, Patent No. [US20097611630, 20097611630]
[2]   A thermally responsive biopolymer for intra-articular drug delivery [J].
Betre, Helawe ;
Liu, Wenge ;
Zalutsky, Michael R. ;
Chilkoti, Ashutosh ;
Kraus, Virginia B. ;
Setton, Lori A. .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) :175-182
[3]   STUDIES OF PHARMACOKINETICS AND THERAPEUTIC EFFECTS OF GLUCOCORTICOIDS ENTRAPPED IN LIPOSOMES AFTER INTRAARTICULAR APPLICATION IN HEALTHY RABBITS AND IN RABBITS WITH ANTIGEN-INDUCED ARTHRITIS [J].
BONANOMI, MH ;
VELVART, M ;
STIMPEL, M ;
ROOS, KM ;
FEHR, K ;
WEDER, HG .
RHEUMATOLOGY INTERNATIONAL, 1987, 7 (05) :203-212
[4]   In vitro evaluation and intra-articular administration of biodegradable microspheres containing naproxen sodium [J].
Bozdag, S ;
Çalis, S ;
Kas, HS ;
Ercan, MT ;
Peksoy, I ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 2001, 18 (04) :443-456
[5]   Use of an isolated joint model to detect early changes induced by intra-articular injection of paclitaxel-impregnated polymeric microspheres [J].
Bragdon, B ;
Bertone, AL ;
Hardy, J ;
Simmons, EJ ;
Weisbrode, SE .
JOURNAL OF INVESTIGATIVE SURGERY, 2001, 14 (03) :169-182
[6]   Intra-articular drug delivery systems for the treatment of rheumatic diseases: A review of the factors influencing their performance [J].
Butoescu, N. ;
Jordan, O. ;
Doelker, E. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 73 (02) :205-218
[7]   Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: Physicochemical and magnetic properties, in vitro and in vivo drug release [J].
Butoescu, Nicoleta ;
Jordan, Olivier ;
Burdet, Pierre ;
Stadelmann, Pierre ;
Petri-Fink, Alke ;
Hofmann, Heinrich ;
Doelker, Eric .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 72 (03) :529-538
[8]  
Centers for Disease Control and Prevention, 2012, ARTHR
[9]  
Chowdhary RK, 1998, BIOPHARM DRUG DISPOS, V19, P395, DOI 10.1002/(SICI)1099-081X(199809)19:6<395::AID-BDD117>3.0.CO
[10]  
2-9